The call reflects strong overall performance with significant revenue and profitability growth, especially in the MACI and Burn Care segments. However, challenges in Epicel revenue conversion and adjusted guidance for the Burn Care segment present areas of concern.

Company Guidance -

Q3 2025

In the Vericel Corporation Second Quarter 2025 Earnings Call, the company reported a solid financial performance with significant revenue growth, margin expansion, and increased profitability. Total revenue rose by 20%, with gross margins expanding by over 400 basis points to 74%. Adjusted EBITDA increased by 112% compared to the previous year, reaching over $13 million. MACI generated record second-quarter revenue of nearly $54 million, marking a 21% increase from the prior year, driven by strong underlying business fundamentals and the expansion of the MACI surgeon base. For Burn Care, Epicel showed a strong rebound with a substantial increase in biopsies and grafts, reaching the highest biopsy numbers since 2023. The company's guidance for the full year includes maintaining MACI revenue growth in the low 20% range, with anticipated third-quarter revenue growth similarly in the low 20% range, and a reaffirmed profitability guidance of a 74% gross margin and a 26% adjusted EBITDA margin.

Record Revenue Growth

Total revenue for Q2 2025 increased 20% year-over-year, reaching $63.2 million. This was driven by strong performance in the MACI and Burn Care segments.

Significant Profitability Improvement

Adjusted EBITDA increased 112% versus the prior year to over $13 million, with a gross margin expansion of more than 400 basis points to 74%.

MACI's Record Performance

MACI generated record second quarter revenue of nearly $54 million, representing 21% growth versus the prior year, driven by strong business fundamentals and surgeon training.

Epicel and NexoBrid Surge

Epicel revenue increased 11% year-over-year with a 40% increase in biopsies. NexoBrid revenue grew 52% year-over-year with strong hospital orders.

Strategic Sales Force Expansion

Vericel is expanding its MACI sales force from 76 to approximately 100 territories to support expected volume growth.

Progress in Clinical Trials

FDA clearance was received for the MACI ankle clinical study, expected to be a major growth driver as it expands into other orthopedic markets.

Vericel (VCEL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

VCEL Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 06, 2025	2025 (Q3)	>-0.01 / -	-0.02	―	―	―
Jul 31, 2025	2025 (Q2)	-0.03 / -0.01	-0.1	90.00% (+0.09)
May 08, 2025	2025 (Q1)	-0.12 / -0.23	-0.08	-187.50% (-0.15)
Feb 27, 2025	2024 (Q4)	0.32 / 0.38	0.26	46.15% (+0.12)
Nov 07, 2024	2024 (Q3)	-0.05 / -0.02	-0.08	75.00% (+0.06)
Aug 01, 2024	2024 (Q2)	-0.09 / -0.10	-0.11	9.09% (<+0.01)
May 08, 2024	2024 (Q1)	-0.11 / -0.08	-0.16	50.00% (+0.08)
Feb 29, 2024	2023 (Q4)	0.17 / 0.26	0.12	116.67% (+0.14)
Nov 08, 2023	2023 (Q3)	-0.12 / -0.08	-0.14	42.86% (+0.06)
Aug 02, 2023	2023 (Q2)	-0.15 / -0.11	-0.19	42.11% (+0.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

VCEL Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$40.66	$34.94	-14.07%
May 08, 2025	$40.47	$41.87	+3.46%
Feb 27, 2025	$52.85	$49.62	-6.11%
Nov 07, 2024	$48.04	$50.03	+4.14%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Vericel Corp (VCEL) report earnings?

Vericel Corp (VCEL) is schdueled to report earning on Nov 06, 2025, TBA (Confirmed).

What is Vericel Corp (VCEL) earnings time?

Vericel Corp (VCEL) earnings time is at Nov 06, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is VCEL EPS forecast?

VCEL EPS forecast for the fiscal quarter 2025 (Q3) is >-0.01.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing